Homo sapiens

Chapter 145 Press Conference (Part 2)

"The second new drug is the anti-drug No. 4 special drug—Langfu Anning..."

Rangfu is at peace? Xie Bin's eyes widened immediately, Langfu? Being proficient in English, he immediately began to think about this term. Could this English transliteration be...?

Tian Hemeng pointed to the big screen on the stage and said: "This is the treatment range, usage method, therapeutic effect, and drug contraindications of Langfu's tranquilizing medicine..."

Everyone was already staring at the big screen.

‘Targeted viral antibiotics have actually been developed. ’ Martin from Roche was very surprised, and at the same time he was also uncontrollably greedy.

There are many representatives of Europa Pharmaceuticals who think the same way as him.

Apparently they've seen the huge benefits.

The representatives of several pharmaceutical companies from China, including Sinopharm Group, Yangtze River Pharmaceuticals, Yangcheng Pharmaceuticals, etc., also showed uncertain expressions at this time.

In fact, the representatives of these pharmaceutical companies did not come specifically to participate in the press conference, but they have a lot of business cooperation with Qingye Medical, so they set up an office in Binmana.

Participating in the press conference is just to give face and come to support me.

But they didn't expect that Qingye Medical would make another big move. The person in charge of Sinopharm's office responded the fastest. He directly asked his assistant to send an email to the headquarters.

The scene quickly became chaotic, with representatives from many companies trying their best to contact the headquarters to report on Qingye Medical’s new drugs.

In particular, Tian Hemeng projected many patient medication reports on the big screen. Although special medicines cannot allow patients to obtain antibodies, they can at least save their lives.

Xie Bin, who had already received special authorization from the board of directors, stood up very simply and walked towards Tian Hemeng.

The same action was taken by Harry from Homo Sapien Company.

Before Tian Hemeng could step off the stage, he was intercepted by Xie Bin and Harry coming towards him.

Xie Bin couldn't wait to say: "Mr. Tian, ​​is there any discount on the price of the special medicine? If the price is right, our company is willing to purchase 100,000 boxes."

He is very aware of the drug production scale of Qingye Medical. It is estimated that the production volume of anti-toxic No. 4-Langfu Anning will not exceed hundreds of thousands of boxes per month. If he does not start quickly, the day lily will be cold.

"Our company also needs 100,000 boxes. How about the price of 4,500 gold yuan per box?" Harry smiled and bargained.

But Tian Hemeng has no intention of giving in: "5,000 is the lowest price. After all, our company needs to invest a lot of research and development expenses."

Harry paused for a moment, as if he was worried that Xie Bin would steal business, so he gritted his teeth and agreed: "Then it will be 5,000 gold yuan per box. I hope these 100,000 boxes can be supplied first."

Damn it! Before Xie Bin could say anything, Harry directly ordered 100,000 boxes.

He was worried that other companies would come over, and he didn't care about the discounts. He said like a knife to cut through the mess: "Mr. Tian, ​​it's only 5,000 gold yuan per box. Please arrange 100,000 boxes for our company as soon as possible."

"Haha, no problem." Tian Hemeng agreed with a smile on her face. For so many years in pharmaceutical sales, this was the first time she encountered a contract that didn't involve wrangling.

Sure enough, technology is the primary productive force.

The two contracts received 1 billion gold dollars in funding.

When the representatives of other companies saw this scene, they even cursed Homo Sapiens Company and Zhengda Company in their hearts, but their pace quickened.

In particular, Samsung Consortium, Taisho Pharmaceutical, and Kobayashi Pharmaceutical deliberately formed a human wall to surround Tian Hemeng, blocking people from other companies and letting their own people talk first.

On the contrary, Europa Pharmaceuticals and Huaguo Pharmaceuticals are relatively calm, or rather helpless.

Because drug import is not a casual matter, small countries can open green channels at will, but the European Union and China cannot easily approve it.

Pharmaceutical companies also want to make money, but the problem is that it is useless to sign a contract now. If Qingye Medical's new drugs fail to pass local review, they will be embarrassed by then.

Especially for Europa, it is estimated that it will be difficult for Qingye Medical’s new drugs to pass review.

Roche's Martin, Bayer's Carl and others all showed a wry smile. After all, they knew very well that AstraZeneca's urine properties would most likely secretly prevent Aoba Medical's new drugs from entering Europa.

In the face of profit, they will not pay attention to the painful cries of patients.

Unless Qingye Medical is willing to give drug agency rights to AstraZeneca.

However, since Roche is headquartered in the Alpine Federation, Martin is confident that he can convince the company's board of directors to allow new drugs to enter the Alpine Federation.

Therefore, pharmaceutical companies from various countries are now showing off their magical powers, hoping to persuade local governments to open green channels for Qingye Medical's new drugs so that they can make money from them.

As for pharmaceutical companies that are developing vaccines themselves, they are also in trouble.

Qingye Medical doesn't care about the entanglements and various small moves of pharmaceutical companies from various countries.

Anyway, the medicine is in Hongsawady. As for whether you allow these new medicines to be put on the market, that is your own business. Don’t even think about asking Qingye Medical to apply and go through the process.

Chia Tai Company, which has figured out the temper of Qingye Medical, plans to quickly promote the listing of Anti-drug No. 4, Langfu Anning, in Southeast Asia through the Royal Power Group of Siam and several large business families in other Southeast Asian countries.

Homo sapiens company also cooperates with a number of small island countries in the Pacific and Latin American countries.

South Korea and Japan, which are severely affected by the consortium, can also give the green light to new drugs.

The afternoon passed.

Tian Hemeng has signed 13 contracts with a total value of 4.2 billion gold yuan.

Li Qingye was quite satisfied with the development of Qingye Medical. He did not disturb Tian Hemeng, but quietly left through the special passage with Mao Siqiang, Feili and others.

But as soon as he walked out of the door, he met several Tianzhu people who smelled like curry.

"Bana, their company is just going too far. They asked us to pay the full price."

"That is, we are willing to purchase their medicines, but they still ask for a lot. It is so insincere."

Listening to the curry-flavored English and the pride and dissatisfaction in their words, Li Qingye shrugged and got on the off-road vehicle.

Maang Siqiang couldn't help but laugh: "The boss is laughing, mainly because he is doing business with people from Tianzhu, and he won't ship the goods without full payment. This is an unspoken rule in the industry."

"I know, by the way, do the people of Tianzhu have enough gold and yuan reserves?"

Maang Siqiang shook his head: "Probably not. We imported a batch of generic drugs from Tianzhu some time ago, about more than five million gold yuan, and these guys came directly to pick up the gold and take it back."

"It doesn't matter, they will send the gold back." Li Qingye said with a smile.

The situation is exactly as Li Qingye said. Due to insufficient gold and dollar reserves, rich people in Tianzhu dare not use smuggled drugs casually. As a last resort, they can only fly to Yangon for treatment.

These wealthy people in Tianzhu exchange the gold they carry with them for gold dollars at Qingye Bank in Yangon, and then go to nearby sanatoriums for treatment.

To empty out the gold in Hongsawati, the people of Tianzhu are just fanciful.

Especially with the launch of the special medicine Langfu Ting Ning, rich people from Tianzhu who are afraid of death are expected to come to Yangon for treatment in greater numbers.

Li Qingye saw the key clearly, so he didn't take Tianzhu Enterprise's exchange of gold seriously.

To cash out the gold in Hongsawady on a large scale, a clear trade deficit must occur. However, the gold-dollar trading system in Hongsawady is now becoming more and more balanced.

The so-called balanced trade assumes that the other party purchases our goods worth 10 billion gold dollars, and we also purchase the other party's goods worth 10 billion gold dollars, achieving a mutual offset effect.

In this case, the gold dollar will return to the hands of Aoba Bank in a matter of seconds.

Even if the expenditure occasionally exceeds the limit, the other party will most likely not use the extra gold dollars casually, but will use them as reserves.

Moreover, Aoba Bank is not afraid of exchange by the other party. After all, it produces 3 to 5 tons of gold every month. As long as the circulation is controlled, the gold dollar will be extremely strong.

In fact, through the sale of medicines, test strips, rice, timber and agricultural products, Hongsawady's exports have certain advantages.

If we do not expand the import of materials and products, Hongsawady will soon become a country with a net inflow of gold.

Li Qingye had already noticed this problem by checking internal intelligence.

In the first half of this year, the inflow of Hongsawady gold was 1,728 kilograms, while the outflow was only 341 kilograms.

With the launch of new drugs, it is expected that there will be another wave of gold inflows.

Thank you for your support (ω`), please subscribe, collect, monthly votes and recommendation votes.

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like